Potential Application Beyond Weight Loss There is some therapeutic potential for GLP-1 receptor agonists beyond weight loss, with early research showing promising implications for treating various metabolic and cardiovascular conditions
High BMI Your doctor may prescribe GLP-1 drugs if you have a high body mass index (BMI) of 30 or more
The hurdle to dietary regulation being implemented as a medical intervention can be owed a large extent to our lack of understanding of molecular mechanisms and their concurrent effect on disease progression and outcome [126, 127]
Kanhai KMS, Zuiker RGJA, Stavrakaki I, Gladdines W, Gaillard PJ, Klaassen ES, et al
More than 6.3% of households in Great Britain now include at least one GLP-1 user, according to the research by Worldpanel by Numerator